companydata.dkcompanydata.dk

C4PAIN ApS: Financial statements 2025

CVR: 32292402

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

C4PAIN ApS (CVR 32292402) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. That is a decrease of 87.3% compared with the year before. Equity in the 2025 report amounted to DKK 4,164,765. The solvency ratio was 95.4%. The company had 1 employee in the financial year.

Gross Profit
DKK 159,243
Profit/Loss
DKK 185,909
Equity
DKK 4,164,765
Total Assets
DKK 4,366,045
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-159 t.186 t.4.2 mio.1
2024-1.3 mio.1.1 mio.4 mio.-
2023-28 t.97 t.2.9 mio.-
2022-252 t.237 t.2.8 mio.-
2021-53 t.70 t.2.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is C4PAIN ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

C4PAIN ApS: The 2024 annual report is outJun 23, 2025

C4PAIN ApS has published its annual report for 2024. Gross profit came to DKK 1,257,321, and the net result was DKK 1,074,600.

About C4PAIN ApS

C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity in the 2025 report amounted to DKK 4,164,765.

Source: annual report 2025, Danish Business Authority